MARKET

QDEL

QDEL

Quidel
NASDAQ

Real-time Quotes | Nasdaq Last Sale

110.20
-1.63
-1.45%
Opening 14:12 06/22 EDT
OPEN
111.75
PREV CLOSE
111.82
HIGH
111.80
LOW
109.75
VOLUME
158.58K
TURNOVER
--
52 WEEK HIGH
306.72
52 WEEK LOW
103.31
MARKET CAP
4.69B
P/E (TTM)
5.07
1D
5D
1M
3M
1Y
5Y
5 Value Stocks To Watch In The Healthcare Sector
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value st...
Benzinga · 1d ago
Harvest ETFs June 2021 Distributions
Harvest Portfolios Group Inc. ("Harvest") announces the following distributions for Harvest ETFs for the month ending June 30, 2021. The distribution will be paid on or about July 9, 2021 to unitholders of record on June 30, 2021 with an ex-dividend date o...
CNW Group · 1d ago
Quidel (QDEL) Gains As Market Dips: What You Should Know
Zacks.com · 3d ago
Zacks Value Investor Highlights: Hibbett Sports, CoDiagnostics, Quidel Corp, DHT Holdings and Rocket Companies
Zacks.com · 4d ago
Screening for Ben Graham Value Stocks
Zacks.com · 5d ago
--Craig-Hallum Adjusts Quidel's Price Target to $219 From $296, Reiterates Buy Rating
MT Newswires · 5d ago
Insider Trends: Insider at Quidel Acquires Stock Via Conversion of Option/Derivative Security Sells Portion to Pay Tax, Buy Trend Intact
MT Newswires · 5d ago
Monday’s Pre-Market: Here’s What You Need to Know Before the Market Opens
U.S. stock futures were mixed on Monday as S&P 500 recorded an all-time high at the end of last week, reflecting the third consecutive week of gains. Dow futures were trading around 0.1% lower, while Nasdaq and S&P futures had gained about 0.3% and 0.1%, r...
TipRanks · 06/14 12:42
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of QDEL. Analyze the recent business situations of Quidel through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average QDEL stock price target is 151.25 with a high estimate of 219.00 and a low estimate of 86.00.
EPS
Institutional Holdings
Institutions: 463
Institutional Holdings: 40.68M
% Owned: 95.61%
Shares Outstanding: 42.55M
TypeInstitutionsShares
Increased
136
5.56M
New
60
1.39M
Decreased
114
3.13M
Sold Out
94
1.93M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.69%
Healthcare Equipment & Supplies
+0.46%
Key Executives
Non-Executive Chairman/Independent Director
Kenneth Buechler
Chief Executive Officer/President/Director
Douglas Bryant
Chief Financial Officer
Randall Steward
Chief Operating Officer
Robert Bujarski
Senior Vice President/General Counsel
Michelle Hodges
Senior Vice President
William Ferenczy
Senior Vice President
Karen Gibson
Senior Vice President
Werner Kroll
Senior Vice President
Tamara Ranalli
Senior Vice President
Edward Russell
Independent Director
Edward Michael
Independent Director
Kathy Ordonez
Independent Director
Mary Polan
Independent Director
Ann Rhoads
Independent Director
Charles Slacik
Independent Director
Matthew Strobeck
Independent Director
Ken Widder
Independent Director
Kenneth Widder
Independent Director
Joseph Wilkins
No Data
  • All
  • Financials
  • Insiders
More
About QDEL
Quidel Corp. is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: rapid immunoassays, cardiac immunoassay, specialized diagnostic solutions and molecular diagnostic solutions. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Its diagnostic solutions aid in the detection and diagnosis of many diseases and medical conditions, including infectious diseases, cardiovascular diseases and conditions, women’s health, gastrointestinal diseases, autoimmune diseases, bone health and thyroid diseases. The Company provides diagnostic testing solutions under various brand names, including Quidel, QuickVue, QuickVue+, D3 FastPoint, Super E-Mix, ELVIS, Sofia, Amplivue, Lyra and Thyretain.

Webull offers kinds of Quidel Corporation stock information, including NASDAQ:QDEL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QDEL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading QDEL stock methods without spending real money on the virtual paper trading platform.